Josh Peters

Josh Peters is the CEO and Co-founder of Prox Biosciences, a seed-stage biotech company based in Cambridge, Massachusetts. He completed his PhD in Biological/Biosystems Engineering at the Massachusetts Institute of Technology (MIT), where his research focused on utilizing -omic methods to model and engineer immune cell states.1

Professional Background

• Current Role:
  • CEO and Co-founder at Prox Biosciences since January 2024.
• Previous Experience:
  • Venture Associate at 82VS (September 2022 - January 2024).
  • Senior Associate at the American Cancer Society's BrightEdge Fund (December 2021 - August 2022).
  • Co-Founder of Area Two Bio Fund (July 2021 - July 2022).
  • Bio-IT Fellow at 8VC (March 2021 - May 2021) and Amgen Scholar at MIT (June 2016 - August 2016) among other roles.1

Education

• PhD: Biological/Biosystems Engineering, Massachusetts Institute of Technology.
• Bachelor’s Degree: Chemical Engineering, University of Pittsburgh.1

Josh Peters is recognized for his strong background in biological engineering and venture capital, contributing significantly to scientific innovation and startup support in the biotech field.